Is BHC.TO undervalued or overvalued?

As of 2025-03-19, the Intrinsic Value of Bausch Health Companies Inc (BHC.TO) is 9.21 CAD. This BHC.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 10.05 CAD, the upside of Bausch Health Companies Inc is -8.30%. This means that BHC.TO is overvalued by 8.30%.

The range of the Intrinsic Value is (21.22) - 122.95 CAD

	Range	Selected	Upside
a
DCF (Growth 5y)	(21.22) - 122.95	9.21	-8.3%
DCF (Growth 10y)	(15.25) - 132.53	16.42	63.4%
DCF (EBITDA 5y)	(26.64) - 3.60	(1,773.85)	-123450.0%
DCF (EBITDA 10y)	(18.31) - 25.24	(1,773.85)	-123450.0%
Fair Value	-0.90 - -0.90	-0.90	-108.94%
P/E	(4.12) - 15.45	3.82	-62.0%
EV/EBITDA	(8.14) - 24.53	7.56	-24.7%
EPV	26.07 - 131.94	79.01	686.1%
DDM - Stable	(0.75) - (1.79)	(1.27)	-112.6%
DDM - Multi	1.95 - 3.97	2.65	-73.6%